Edgemoor Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-21,145
| Closed | -$1.23M | – | 161 |
|
|
2023
Q3 | $1.23M | Hold |
21,145
| – | – | 0.15% | 81 |
|
|
2023
Q2 | $1.35M | Hold |
21,145
| – | – | 0.15% | 78 |
|
|
2023
Q1 | $1.47M | Hold |
21,145
| – | – | 0.18% | 74 |
|
|
2022
Q4 | $1.52M | Hold |
21,145
| – | – | 0.19% | 76 |
|
|
2022
Q3 | $1.5M | Hold |
21,145
| – | – | 0.2% | 73 |
|
|
2022
Q2 | $1.63M | Hold |
21,145
| – | – | 0.21% | 77 |
|
|
2022
Q1 | $1.54M | Buy |
21,145
+225
| +1% | +$15.1K | 0.16% | 76 |
|
|
2021
Q4 | $1.3M | Buy |
20,920
+800
| +4% | +$46.9K | 0.13% | 75 |
|
|
2021
Q3 | $1.19M | Sell |
20,120
-162,872
| -89% | -$10.7M | 0.14% | 71 |
|
|
2021
Q2 | $12.2M | Sell |
182,992
-7,510
| -4% | -$490K | 1.14% | 33 |
|
|
2021
Q1 | $12M | Buy |
190,502
+1,200
| +0.6% | +$74.7K | 1.21% | 32 |
|
|
2020
Q4 | $11.7M | Buy |
189,302
+3,647
| +2% | +$224K | 1.32% | 28 |
|
|
2020
Q3 | $11.2M | Buy |
185,655
+690
| +0.4% | +$41.5K | 1.38% | 23 |
|
|
2020
Q2 | $10.9M | Buy |
184,965
+14,255
| +8% | +$853K | 1.46% | 21 |
|
|
2020
Q1 | $9.52M | Sell |
170,710
-1,288
| -0.7% | -$78.7K | 1.55% | 20 |
|
|
2019
Q4 | $11M | Buy |
171,998
+2,493
| +1% | +$143K | 1.26% | 29 |
|
|
2019
Q3 | $8.6M | Buy |
169,505
+359
| +0.2% | +$16.9K | 1.06% | 39 |
|
|
2019
Q2 | $7.67M | Buy |
169,146
+31,518
| +23% | +$1.47M | 0.97% | 40 |
|
|
2019
Q1 | $6.57M | Buy |
+137,628
| New | +$6.86M | 0.86% | 38 |
|
|
2018
Q4 | – | Sell |
-3,701
| Closed | -$230K | – | 129 |
|
|
2018
Q3 | $230K | Hold |
3,701
| – | – | 0.03% | 129 |
|
|
2018
Q2 | $205K | Hold |
3,701
| – | – | 0.03% | 132 |
|
|
2018
Q1 | $234K | Hold |
3,701
| – | – | 0.03% | 127 |
|
|
2017
Q4 | $222K | Hold |
3,701
| – | – | 0.03% | 134 |
|
|
2017
Q3 | $236K | Hold |
3,701
| – | – | 0.03% | 131 |
|
|
2017
Q2 | $206K | Sell |
3,701
-1
| -0% | -$54 | 0.03% | 131 |
|
|
2017
Q1 | $201K | Buy |
+3,702
| New | +$203K | 0.03% | 122 |
|
|
2016
Q3 | – | Sell |
-3,005
| Closed | -$221K | – | 120 |
|
|
2016
Q2 | $221K | Buy |
+3,005
| New | +$212K | 0.03% | 115 |
|
|
2016
Q1 | – | Sell |
-3,005
| Closed | -$207K | – | 123 |
|
|
2015
Q4 | $207K | Buy |
+3,005
| New | +$199K | 0.03% | 131 |
|
Other funds holding BMY
Edgemoor Investment Advisors's BMY Position: Q4 2023 in Review
Edgemoor Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 21,145 shares — an estimated $1.23M sold.
Edgemoor Investment Advisors first reported a position in BMY in Q4 2015 and held it in 28 quarters. The position peaked at $12.2M in Q2 2021. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.
- Edgemoor Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
- Edgemoor Investment Advisors sold 21,145 Bristol-Myers Squibb shares in Q4 2023, an estimated $1.23M.
- Edgemoor Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 28 quarters.
- Edgemoor Investment Advisors's Bristol-Myers Squibb position peaked at $12.2M in Q2 2021.
- 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.
Based on Edgemoor Investment Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.